A Systematic Review of Vaccine-Induced Sarcoidosis Suggests Increased Risk of Sarcoidosis Following COVID-19 mRNA Vaccine

Abstract

Keywords

vaccine sarcoidosis adverse effect drug-induced sarcoidosis-like reaction systematic review Th1 response

Get full access to this article

View all access options for this article.

References

Lo Schiavo

Ruocco

Gambardella

O’Leary

Gee

. Granulomatous dysimmune reactions (sarcoidosis, granuloma annulare, and others) on differently injured skin areas. Clin Dermatol. 2014;32(5):646-653. doi:10.1016/j.clindermatol.2014.04.012

Mohaghegh

Hatami

Refaghat

Matini

Mohseni Afshar

Aryanian

. Unmasking sarcoidosis following SARS-CoV-2 vaccination: a case report. Clin Case Rep. 2022;10(12):e6660. doi:10.1002/ccr3.6660

Grieco

Rossi

Maddalena

, et al. COVID-19 infection and BNT162b2 vaccine triggering sarcoid-like lesions in the same patient. Response to: sarcoid-like reaction in a patient recovering from COVID-19 pneumonia. JAAD Case Rep. 2022;23:162-163. doi:10.1016/j.jdcr.2021.12.042

Bordry

Costa-Nunes

Cagnon

, et al. Pulmonary sarcoid-like granulomatosis after multiple vaccinations of a long-term surviving patient with metastatic melanoma. Cancer Immunol Res. 2014;2(12):1148-1153. doi:10.1158/2326-6066.CIR-14-0143

Canu

Doutre

. Regression of sarcoidosis skin lesions after receiving the Moderna anti-coronavirus disease 2019 vaccine. J Dermatol. 2022;49(10):e378-e380. doi:10.1111/1346-8138.16438

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.26 MB